Skip to main content
SpringerLink
Log in

Time Course of Drug Effect

  • Chapter
Pharmacokinetics of Drugs

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 110))

Abstract

It has been recognized for many years (Sokolow and Edgar 1950; Swisher et al. 1954) that drug effect may on occasion be directly associated with the time course of drug or drug metabolites in the circulation. Subsequently it was also noted that the relationship between drug concentration and response could be quite complex such that the temporal relationship might be difficult to discern on first examination, e.g., warfarin (Nagashima et al. 1969). Wagner (1975) has provided a review of early work on this topic. Sheiner et al. (1979a) illustrated the usefulness of an effect compartment for linking the time course of d-tubocurarine effect to the time course of plasma concentrations. In this way the delay in onset of effect relative to concentration could be explained. Methods for describing the kinetic behavior of drug effects were further systematized by Holford and Sheiner (1981). This chapter will discuss the motivations for characterizing the time course of drug effect, outline some methodological concerns, and present the various mathematical approaches for modeling active drug and placebo effects.

The views expressed in this paper are those of the authors and not necessarily those of the Food and Drug Administration.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abernethy DR (1988) Problematic factors in pharmacodynamic studies. In: Kroboth PD, Smith RB, Juhl RP (eds) Pharmacokinetics and pharmacodynamics: 2. Current problems and potential solutions. Whitney, Cincinnati, p 60

    Google Scholar 

  • Bates DM, Watts DG (1988) Nonlinear regression analysis and its applications. Wiley, New York

    Book  Google Scholar 

  • Beal SL, Sheiner LB (1991) NONMEM users guide. University of California, San Francisco

    Google Scholar 

  • Campbell DB (1990) The use of kinetic-dynamic interactions in the evaluation of drugs. Psychopharmacology 100: 433–450

    Article  PubMed  CAS  Google Scholar 

  • Cheng YE, Paalzow (1990) A pharmacodynamic model to predict the time dependent adaptation of dopaminergic activity during constant concentrations of haloperidol. J Pharm Pharmacol 42: 566 - 571

    Article  PubMed  CAS  Google Scholar 

  • Chiou WL (1991) The significance of marked “universal” dependence of drug concentration on blood sampling site in pharmacokinetics and pharmacodynamics. In: DArgenio DZ (ed) Advanced methods of pharmacokinetic and pharmacodynamic systems analysis. Plenun, New York, pp 37–54

    Google Scholar 

  • Colburn WA (1981) Simultaneous pharmacokinetic and pharmacodynamic modeling. J Pharmacokinet Biopharm 9: 367–388

    Article  PubMed  CAS  Google Scholar 

  • Colburn WA, Blue JW (1992) Using pharmacokinetics and pharmacodynamics to direct pharmaceutical R&D. Appl Clin Trials 1: 42–46

    Google Scholar 

  • Collins JM, Grieshaber CK, Chabner BA (1990) Pharmacologically guided phase I clinical trials based upon preclinical drug development. J Natl Cancer Inst 82: 1321–1326

    Article  PubMed  CAS  Google Scholar 

  • Dingemanse J, Danhof M, Breimer DD (1988) Pharmacokinetic-pharmacodynamic modeling of CNS drug effects: an overview. Pharmacol Ther 38: 1–52

    Article  PubMed  CAS  Google Scholar 

  • Ebling WF, Lee EN, Stanski DR (1990) Understanding pharmacokinetics and pharmacodynamics through computer simulation: 1. The comparative clinical profiles of fentanyl and alfentanil. Anesthesiology 72: 650–658

    Article  PubMed  CAS  Google Scholar 

  • Ekblom M, Gardmark, Hammarlund-Udenaes M (1993) Pharmacokinetics and pharmacodynamics of morphine-3-glucuronide in rats and its influence on the antinociceptive effect of morphine. Biopharm Drug Dispos (in press)

    Google Scholar 

  • Fisher LE, Ludwig EA, Wald JA, Sloan RR, Middleton E Jr, Jusko WJ (1992) Pharmacokinetics and pharmacodynamics of methylprednisolone when administered at 8 AM versus 4 PM. Clin Pharmacol Ther 51: 677–688

    Article  PubMed  CAS  Google Scholar 

  • Francheteau P, Steimer J-L, Dubray C, Lavene D (1991) Mathematical model for in vivo pharmacodynamics integrating fluctuation of the response: application to the prolactin suppressant effect of the dopaminomimetic drug DCN 203–922. J Pharmacokinet Biopharm 19: 287–309

    Article  PubMed  CAS  Google Scholar 

  • Gibaldi M, Perrier D (1982) Pharmacokinetics, 2nd edn. Dekker, New York

    Google Scholar 

  • Girard P, Boissel J-P (1989) Clockwise hysteresis or proteresis. J Pharmacokinet Biopharm 17: 401–402

    Article  PubMed  CAS  Google Scholar 

  • Greenblatt DJ, Ehrenberg BL, Gunderman J, Locniskar A, Scavone JM, Harmatz JS, Shader RI (1989) Pharmacokinetic and electroencephalographic study of intravenous diazepam, midazolam and placebo. Clin Pharmacol Ther 45: 356–365

    Article  PubMed  CAS  Google Scholar 

  • Hill AV (1910) The possible effects of the aggregation of the molecules of haemoglobin on its dissociation curves. J Physiol 40:iv–vii

    Google Scholar 

  • Holford NHG (1986) Clinical pharmacodynamics of warfarin. Clin Pharmacokinet 11: 486–504

    Article  Google Scholar 

  • Holford NHG (1991) Physiological alternatives to the effect compartment model. In: D’Argenio DZ (ed) Advanced methods of pharmacokinetics and pharmacodynamics systems analysis. Plenum, New York, pp 55–60

    Google Scholar 

  • Holford NHG (1992a) Clinical pharmacokinetics and pharmacodynamics: the quantitative basis for therapeutics. In: Melmon KL, Morelli HF, Hoffman BB, Nierenberg DW (eds) Clinical pharmacology; basic principles in therapeutics, 3rd edn. McGraw-Hill, New York

    Google Scholar 

  • Holford NHG (1992b) Parametric models of the time course of drug action: the population approach. In: Rowland M, Aarons L (eds) New strategies in drug development and clinical evaluation: the population approach. EUR 13775. Commission of the European Communities, Brussels, pp 193–206

    Google Scholar 

  • Holford NHG, Peck CC (1992) Population pharmacodynamics and drug development. In: Van Boxtel CJ, Holford NHG, Danhof M (eds) The in vivo study of drug action. Elsevier, Amsterdam

    Google Scholar 

  • Holford NHG, Peace KE (1992a) Methodologic aspects of a population pharmacodynamics model for cognitive effects in Alzheimer’s disease treated with tacrine. Proc Natl Acad Sci USA 89: 11466–11470

    Article  PubMed  CAS  Google Scholar 

  • Holford NHG, Peace KE (1992b) Results and validation of a population pharmacodynamics model for cognitive effects in Alzheimer’s disease treated with tacrine. Proc Natl Acad Sci USA 89: 11471–11475

    Article  PubMed  CAS  Google Scholar 

  • Holford NHG, Sheiner LB (1981) Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models. Clin Pharmacokinet 6: 429–453

    Article  PubMed  CAS  Google Scholar 

  • Holford NHG, Jonkers R, Van Boxtel CJ (1989) Comparison of a physiological pharmacokinetic-pharmacodynamic model with an effect compartment model describing the hypokalaemic effect of terbutaline with and without metoprolol

    Google Scholar 

  • Inturrisi CE, Colburn WQ, Kaiko RF, Houde RW, Foley KM (1987) Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain. Clin Pharmacol Ther 41: 392–401

    Article  PubMed  CAS  Google Scholar 

  • Jonkers RE, Van Boxtel CJ, Koopmans RP, Oosterhuis B (1989) A nonsteady state agonist antagonist interaction model using plasma potassium concentrations to quantify the β2-selectivity of β-blockers. J Pharmacol Exp Ther 249: 297–302

    PubMed  CAS  Google Scholar 

  • Kelman AW, Sumner DJ, Whiting B (1981) Systolic time interval v. heart rate regression equations using atropine: reproducibility studies. Br J Clin Pharmacol 12: 15–20

    PubMed  CAS  Google Scholar 

  • Kenakin T (1987) Pharmacologic analysis of drug-receptor interaction. Raven, New York

    Google Scholar 

  • Kenakin T (1992) The study of drug-receptor interactions in in vivo systems. In: Van Boxtel CJ, Holford NHG, Danhof M (eds) The in vivo study of drug action. Elsevier, Amsterdam

    Google Scholar 

  • Levy G (1985) Variability in animal and human pharmacodynamic studies. In: Rowland M, Sheiner LB, Steimer J-L (eds) Variability in drug therapy. Raven, New York, p 125

    Google Scholar 

  • Nagashima R, O’Reilly RA, Levy G (1969) Kinetics of pharmacologic effects in man: the anticoagulant action of warfarin. Clin Pharmacol Ther 10: 22–35

    PubMed  CAS  Google Scholar 

  • Paalzow LK (1992) Measurement and modeling of analgesic drug effect. In: Van Boxtel CJ, Holford NHG, Danhof M (eds) The in vivo study of drug action. Elsevier, Amsterdam

    Google Scholar 

  • Peck CC, Nichols Al, Baker J, Lenert LL, Ezra D (1985) Clinical pharmacodynamics of theophylline. J Allergy Clin Immunol 76: 292–297

    Article  PubMed  CAS  Google Scholar 

  • Peck CC, Barr WH, Benet LZ et al. (1992) Opportunities for integration of pharmacokinetics, pharmacodynamics and toxicokinetics in rational drug development. Clin Pharmacol Ther 51: 465–473

    Article  PubMed  CAS  Google Scholar 

  • Perry PJ, Pfahl BM, Holstad SG (1987) The relationship between antidepressant response and tricyclic antidepressant plasma concentrations. Clin Pharmacokinet 13: 381–392

    Article  PubMed  CAS  Google Scholar 

  • Porchet HC, Benowitz NL, Sheiner LB (1988) Pharmacodynamic model of tolerance: application to nicotine. J Pharmacol Exp Ther 244: 231–236

    PubMed  CAS  Google Scholar 

  • Ratain MJ, Schilsky RL, Conley BA, Egorin MJ (1990) Pharmacodynamics in cancer therapy. J Clin Oncol 8: 1739–1753

    PubMed  CAS  Google Scholar 

  • Rowland M, Tozer TN (1989) Clinical pharmacokinetics: concepts and applications, 2nd edn. Lea and Febiger, Philadelphia

    Google Scholar 

  • Sanaathanan LP, Peck CC (1991) The randomized concentration-controlled trial: an evaluation of its sample size efficiency. Controlled Clin Trials 12: 780–794

    Article  Google Scholar 

  • Scott JC, Stanski DR (1987) Decreased fentanyl and alfentanil dose requirements with age. A simultaneous pharmacokinetic and pharmacodynamic evaluation. J Pharmacol Exp Ther 240: 159–172

    PubMed  CAS  Google Scholar 

  • Seber GAF, Wild CJ (1989) Nonlinear regression. Wiley, New York Segre G (1968) Kinetics of interaction between drugs and biological systems. II Farmaco 23: 907–918

    Google Scholar 

  • Shah VP, Midha KK, Dighe S, McGilveray IJ, Skelly JP, Yacobi A, Layloff T, Viswanathan CT, Cook CE, McDowall RD, Pittman KA, Spector S (1992) Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Pharm Res 9: 588–592

    Article  Google Scholar 

  • Sheiner LB (1989) Clinical pharmacology and the choice between theory and empiricism. Clin Pharmacol Ther 46: 605–615

    Article  PubMed  CAS  Google Scholar 

  • Sheiner LB (1991) The intellectual health of clinical drug evaluation. Clin Pharmacol Ther 50: 4–9

    Article  PubMed  CAS  Google Scholar 

  • Sheiner LB, Stanski DR, Vozeh S, Miller RD, Ham J (1979a) Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine. Clin Pharmacol Ther 25: 358–371

    PubMed  CAS  Google Scholar 

  • Sheiner LB, Beal SL, Rosenberg B (1979b) Forecasting individual pharmacokinetic parameters. Clin Pharmacol Ther 26: 294–305

    PubMed  CAS  Google Scholar 

  • Sokolow M, Edgar AL (1950) Blood quinidine concentration as a guide in the treatment of cardiac arrhythmias. Circulation 1: 576–592

    Google Scholar 

  • Stanski DR (1992) Pharmacodynamic modeling of anesthetic EEG drug effects. Annu Rev Pharmacol Toxicol 32: 423–447

    Article  PubMed  CAS  Google Scholar 

  • Stanski DR, Maitre PO (1990) Population pharmacokinetics and pharmacodynamics of thiopental: the effect of age revisited. Anesthesiology 72: 412–422

    Article  PubMed  CAS  Google Scholar 

  • Svec JM, Coleman RW, Mungall DR, Ludden TM (1985) Bayesian pharmacokinetics/pharmacodynamic forecasting of prothrombin response to warfarin therapy: preliminary evaluation. Ther Drug Monit 7: 174–180

    Article  PubMed  CAS  Google Scholar 

  • Swisher WP, Wedell HG, Cheng JTO (1954) Studies of quinidine plasma levels and rate of decline following cessation of quinidine administration. Am Heart J 47: 449–452

    Article  PubMed  CAS  Google Scholar 

  • Unadkat JD, Sheiner LB, Hennis PJ, Cronnelly R, Miller RD, Sharma M (1986) An integrated model for the interaction of muscle relaxants with their antagonists. J Appl Physiol 61: 1593–1598

    PubMed  CAS  Google Scholar 

  • Van Boxtel CJ, Holford NHG, Danhof M (1992) The in vivo study of drug action. Elsevier, Amsterdam

    Google Scholar 

  • Verotta D, Kitts J, Rodriguez R, Coldwell J, Miller RD, Sheiner LB (1991) Reversal of neuromuscular blockade in humans by neostigmine and edrophonium: a mathematical model. J Pharmacokinet Biopharm 19: 713–729

    Article  PubMed  CAS  Google Scholar 

  • Vozeh S, Bindschedler M, Ha H-R, Kaufmann G, Guentert TW, Follath F (1987) Pharmacodynamics of 3-hydroxyquinidine alone and in combination with quinidine in healthy persons. Am J Cardiol 59: 681–684

    Article  PubMed  CAS  Google Scholar 

  • Wagner J (1975) Fundamentals of clinical pharmacokinetics. Drug Intelligence Publications, Hamilton

    Google Scholar 

Download references

Authors
  1. N. H. G. Holford
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. M. Ludden
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Pharmacokinetics/Drug Metabolism Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company, 2800 Plymouth Road, 48105-1047, Ann Arbor, MI, USA

    Peter G. Welling Ph.D., D.Sc. (Vice President) (Vice President)

  2. Clinical Research Unit, Department of Psychiatry, 47, Rue du XXXI Décembre, CH-1207, Geneva, Switzerland

    Luc P. Balant Ph.D. (Reader) (Reader)

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Holford, N.H.G., Ludden, T.M. (1994). Time Course of Drug Effect. In: Welling, P.G., Balant, L.P. (eds) Pharmacokinetics of Drugs. Handbook of Experimental Pharmacology, vol 110. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78680-8_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-78680-8_11

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-78682-2

  • Online ISBN: 978-3-642-78680-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation